HIV, cancer, and aging

Article

<< Previous

Next >>

Contents Vol 8(4)

doi:10.1071/SH11048

Publishing on sexual health from the widest perspective

	Search




	Advanced Search



	Journal Home

	About the Journal

	Editorial Committee

	Contacts



	Content

	Online Early

	Current Issue

	Just Accepted

	All Issues

	Online Early

	Special Issues

	Sample Issue



	For Authors

	General Information

	Instructions to Authors

	Submit Article

	Open Access



	For Referees

	Referee Guidelines

	Review Article

	Annual Referee Index



	For Advertisers



	For Subscribers

	Subscription Prices

	Customer Service

	Print Publication Dates

e-Alerts

Subscribe to our Email Alert or

feeds for the latest journal papers.

Connect with us

Interview with Kit Fairley

Hear Kit Fairley speak about what is sexual health.

HIV, cancer, and aging

Andrew E. Grulich ^A ^C, Fengyi Jin ^A, I. Mary Poynten ^A and Claire M. Vajdic ^B

^A Kirby Institute (formerly the National Centre in HIV Epidemiology and Clinical Research), University of New South Wales, Sydney, NSW 2010, Australia.
^B Prince of Wales Clinical School and Lowy Cancer Research Centre, Faculty of Medicine, University of New South Wales, Sydney, NSW 2052, Australia.
^C Corresponding author. Email: Agrulich@kirby.unsw.edu.au

Sexual Health 8(4) 521-525 http://dx.doi.org/10.1071/SH11048
Submitted: 15 March 2011 Accepted: 6 May 2011 Published: 29 July 2011





	PDF (127 KB) $25



	Export Citation

Print

Abstract

As people with HIV age, they will experience increasing rates of all diseases of aging, including cancer. However, the pattern of higher cancer risk in people with HIV is mostly explained by the chronic effects of certain oncogenic infections, and is not consistent with a syndrome of accelerated aging. Many of those cancers that are most closely associated with aging do not occur at increased rates in people with HIV compared with the general population. The risk of many infection-associated cancers in people with HIV is closely related to the degree of immune deficiency, and for some types of cancer, it is also associated with ongoing HIV replication. Thus, if HIV therapy can provide durable HIV suppression and maintain near normal levels of immune function, the excess risk of cancer is likely to be minimised. While avoidance of profound immunity will greatly reduce cancer risk, it is unclear how close to normal immune function must be to minimise HIV-associated cancer risk. People with HIV are also at a high risk of cancer because they have high rates of lifestyle risks for cancer, in particular tobacco and alcohol exposure. For most cancers, it is appropriate to follow general population guidelines on cancer screening. The exception is cervical cancer, for which annual screening is recommended. In addition, active research is required to establish whether anal cancer screening would prevent the unacceptably high levels of morbidity caused by this disease in people with HIV, most particularly in gay men.

Additional keywords: AIDS, cancer risk, immune deficiency.

References

[1] Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 2007; 370: 59–67.
| CrossRef |

[2] Deeks SG. HIV Infection, inflammation, immunosenescence, and aging. Annu Rev Med 2011; 62: 141–55.
| CrossRef |

[3] Australian Institute of Health and Welfare. Cancer in Australia 2010: an overview. Cancer series no. 60. Cat. no. CAN 56. Canberra: AIHW; 2010.

[4] Ries LAG, Devesa SS. Cancer incidence, mortality, and patient survival in the United States. In: Schottenfeld DFJ, editor. Cancer epidemiology and prevention, 3rd edition. New York: Oxford University Press; 2006. pp. 139–73.

[5] Engels EA, Brock MV, Chen J, Hooker CM, Gillison M, Moore RD. Elevated incidence of lung cancer among HIV-infected individuals. J Clin Oncol 2006; 24: 1383–8.
| CrossRef |

[6] Shiels MS, Pfeiffer RM, Engels EA. Age at cancer diagnosis among persons with AIDS in the United States. Ann Intern Med 2010; 153: 452–60.

[7] van Leeuwen MT, Vajdic CM, Middleton MG, McDonald AM, Law M, Kaldor JM, et al Continuing declines in some but not all HIV-associated cancers in Australia after widespread use of antiretroviral therapy. AIDS 2009; 23: 2183–90.
| CrossRef |

[8] Franceschi S, Lise M, Clifford GM, Rickenbach M, Levi F, Maspoli M, et al Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study. Br J Cancer 2010; 103: 416–22.
| CrossRef |

[9] Polesel J, Franceschi S, Suligoi B, Crocetti E, Falcini F, Guzzinati S, et al Cancer incidence in people with AIDS in Italy. Int J Cancer 2010; 127: 1437–45.
| CrossRef |

[10] Engels EA, Pfeiffer RM, Goedert JJ, Virgo P, McNeel TS, Scoppa SM, et al Trends in cancer risk among people with AIDS in the United States 1980–2002. AIDS 2006; 20: 1645–54.
| CrossRef |

[11] Patel P, Hanson DL, Sullivan PS, Novak RM, Moorman AC, Tong TC, et al Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992–2003. Ann Intern Med 2008; 148: 728–36.

[12] Shinton R, Beevers G. Meta-analysis of relation between cigarette smoking and stroke. BMJ 1989; 298: 789–94.
| CrossRef |

[13] Doll R, Hill AB. Mortality of British doctors in relation to smoking: observations on coronary thrombosis. Natl Cancer Inst Monogr 1966; 19: 205–68.

[14] Veierod MB, Adami HO, Lund E, Armstrong BK, Weiderpass E. Sun and solarium exposure and melanoma risk: effects of age, pigmentary characteristics, and nevi. Cancer Epidemiol Biomarkers Prev 2010; 19: 111–20.
| CrossRef |

[15] Webster AC, Craig JC, Simpson JM, Jones MP, Chapman JR. Identifying high risk groups and quantifying absolute risk of cancer after kidney transplantation: a cohort study of 15 183 recipients. Am J Transplant 2007; : .
| CrossRef |

[16] Rothman KJ, Greenland S, Lash TL. Modern epidemiology, 3rd edition. Philadelphia: Lippincott Williams and Wilkins; 2008.

[17] Biggar RJ, Kirby KA, Atkinson J, McNeel TS, Engels E. Cancer risk in elderly persons with HIV/AIDS. J Acquir Immune Defic Syndr 2004; 36: 861–8.
| CrossRef |

[18] Thun MJH. Tobacco. In: Schottenfeld DFJ, editor. Cancer epidemiology and prevention, 3rd edition. New York: Oxford University Press; 2006. pp. 217–42.

[19] Giordano TP, Kramer JR. Does HIV infection independently increase the incidence of lung cancer? Clin Infect Dis 2005; 40: 490–1.
| CrossRef |

[20] Doll R, Peto R, Wheatley K, Gray R, Sutherland I. Mortality in relation to smoking: 40 years’ observations on male British doctors. BMJ 1994; 309: 901–11.

[21] Adami HO, Day NE, Trichopoulos D, Willett WC. Primary and secondary prevention in the reduction of cancer morbidity and mortality. Eur J Cancer 2001; 37: S118–27.
| CrossRef |

[22] Guiguet M, Boue F, Cadranel J, Lang JM, Rosenthal E, Costagliola D. Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study. Lancet Oncol 2009; 10: 1152–9.
| CrossRef |

[23] Lodi S, Guiguet M, Costagliola D, Fisher M, de Luca A, Porter K. Kaposi sarcoma incidence and survival among HIV-infected homosexual men after HIV seroconversion. J Natl Cancer Inst 2010; 102: 784–92.
| CrossRef |

[24] Kaplan JE, Benson C, Holmes KH, Brooks JT, Pau A, Masur H. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2009; 58: 1–207.

[25] Smith DP, Supramaniam R, Marshall VR, Armstrong BK. Prostate cancer and prostate-specific antigen testing in New South Wales. Med J Aust 2008; 189: 315–8.

[26] Barratt AL, Stockler MR. Screening for prostate cancer: explaining new trial results and their implications to patients. Med J Aust 2009; 191: 226–9.

[27] Australian Health Ministers’ Advisory Council. Other population health screening issues. Available online at: http://www.cancerscreening.gov.au/internet/screening/publishing.nsf/Content/other-pop-health#skincancer [accessed May 2011].

[28] Daling JR, Weiss NS, Hislop TG, Maden C, Coates RJ, Sherman KJ, et al Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. N Engl J Med 1987; 317: 973–7.
| CrossRef |

[29] Palefsky J. Human papillomavirus-related disease in people with HIV. Curr Opin HIV AIDS 2009; 4: 52–6.
| CrossRef |

[30] Anderson JS, Vajdic C, Grulich AE. Is screening for anal cancer warranted in homosexual men? Sex Health 2004; 1: 137–40.
| CrossRef |

Subscriber Login

	Username: Password:

Legal & Privacy | Contact Us | Help